Printer Friendly Printed from http://www.researchandmarkets.com/reports/237931 Chinese Pharmaceutical Industry Description: The Chinese pharmaceutical industry has increased with an annual average growth rate of 16.72% over the last few decades. However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Gaining access to the WTO will further integrate the Chinese economy into the global economic environment, and Chinese pharmaceutical enterprises will face a huge challenge. Contents: - Executive summary - Foreword - Professor Xiaoming Wu, Chancellor, China Pharmaceutical University - 1. Introduction - 2. An overview of the pharmaceutical industry in China 2.1. Economic reform and the open door policy in context 2.2. The growth of the Chinese pharmaceutical industry 2.3. The structure of the Chinese pharmaceutical industry 2.3.1. Industry output 2.3.2. Import and export 2.3.3. The industry layout 2.4. R&D in China 2.5. Marketing approvals and manufacturing 2.6. Non-Chinese investment enterprises in China - 3. Competing in the international market 3.1. Introduction 3.2. Measuring trading competitiveness 3.3. Potential trading competitiveness - 4. Business opportunities for non-Chinese pharmaceutical firms in China 4.1. Factors affecting business opportunities in China 4.1.1. Chinese Authorities' commitments and administrative measures 4.1.2. Chinese consumer demand for pharmaceutical products 4.2. The factors bringing business opportunities 4.3. How to capture business opportunities 4.4. Which would be the profitable fields for non-Chinese pharmaceutical firms? - 5. Conclusion - 6. Appendices 6.1. Case studies 6.1.1. Sino-Swed Pharmaceutical Corp.LTD (SSPC) 6.1.2. Pfizer (China) Pharmaceuticals Limite 6.2.References 6.3. Glossary 6.4.Source data 6.5.Author's biography Summary: The Chinese pharmaceutical industry has increased with an annual average growth rate of 16.72% over the last few decades. However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Gaining access to the WTO will further integrate the Chinese economy into the global economic environment, and Chinese pharmaceutical enterprises will face a huge challenge. China's entry into the WTO, in December of 2001, opened the door to a lucrative market for foreign companies, and especially for pharmaceutical manufacturers and distributors. Accession to the WTO will bind China by fundamental WTO principles, such as improved transparency and the strengthening of commercial legal procedures. China's WTO commitments also include the tightening of rules on intellectual property, tariff concessions, and permission of foreign distributors' entry into domestic market. These commitments will help reduce the risk of doing business in China and encourage increased flow of trade and investment, enhancing the business opportunities for international pharmaceutical companies and investors. This study provides a comprehensive analysis of the multifaceted pharmaceutical industry and market, based on full and accurate statistics, help guide non-Chinese companies and investors through the many changes transforming the Chinese pharmaceutical sector. Ordering: Order Online - visit http://www.researchandmarkets.com/reports/237931 Order by Fax - using the order form below Order By Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Printed 30/08/2008 11:57:57 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com Order information Please verify that the product information is correct and select the format you require. Product Name: Chinese Pharmaceutical Industry Web Address: http://www.researchandmarkets.com/reports/237931 Office Code: OCHGMKMPUSV Report formats Please enter the quantity of the report format you require. Format Quantity Price Electronic €531.00 Electronic - Site License €2,213.00 Contact information Please enter all the information below in BLOCK CAPITALS. First Name:   Last Name:   Email Address: Job Title: Organisation: Address: City: Postal/Zip Code: Country: Phone Number: Fax Number: Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World Page 2 of 2 Printed 30/08/2008 11:57:57 Payment information Please indicate the payment method you would like to use by selecting the appropriate box.  Pay by Credit Card: American Express Diners Club Master Card Visa Cardholder Name: Expiry Date: / Card Number: CVV Security Code: Issue Date: /   (Diners Club only)  Pay by Check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.  Pay by Wire Transfer: Please transfer funds to: Account number: 83313083 Sort code: 98-53-30 Swift code: ULSBIE2D IBAN number: IE78ULSB98533083313083 Bank Address: Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646)607-1907 or (646)964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World